DXR Daxor Corp: רווח נקי למניה ב-12 החודשים האחרונים
Daxor Corporation (DXR) maintains high profitability due to its ownership of a unique automated analyzer, which eliminates pricing pressure. This chart of annual net income per share visualizes the dynamics of this advantage, while the 1.22 metric indicates the yield status. The BVA-100 system has established the company as the standard in cardiology. To ensure stability, the business is implementing digital ancillary services for laboratories.
%20%D7%A8%D7%95%D7%95%D7%97%20%D7%9C%D7%9E%D7%A0%D7%99%D7%94%20%D7%9C%D7%A9%D7%A0%D7%94%20%D7%9E%D7%AA%D7%92%D7%9C%D7%92%D7%9C%D7%AA&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_DXR_-_Daxor-Corporation_-_Earnings-per-share-for-the-trailing-year "DXR - רווח למניה בשנים עשר החודשים האחרונים Daxor Corporation בטווח 04.07.2022 - 15.11.2026 | 👁️GURU.Markets👁️")
פילוחי מדדים פיננסיים ומדדי שוק עבור Daxor Corp. (DXR)
Stable demand from US hospitals for Daxor Corporation (DXR) equipment creates a reliable foundation for cash flow generation. This market resilience converts directly into net income distributed per common share. This indicator measures the business's actual specific annual income, adjusted for the total number of securities. Analyzing the EPS TTM history allows for the identification of hidden capital degradation prior to official reports. The EPS TTM historical trend serves as a signal for assessing the long-term liquidity of investments.
